EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS IN PATIENTS THROUGH 3 YEARS: UNIFI LONG-TERM EXTENSION

David Rowbotham  ¹     Silvio Danese  ²     Ye Miao  ³     Hongyan Zhang  ³     Remo Panaccione  ⁴     Tadakazu Hisamatsu  ⁵     Waqqas Afif  ⁶     Laurent Peyrin-Biroulet  ⁷     Maria T. Abreu  ⁸     William Sandborn  ⁹     Ellen J. Scherl  ¹⁰     Rupert W Leong  ¹¹     Ramesh P. Arasaradnam  ¹²     Bruce E. Sands  ¹³     Colleen W. Marano  ^13    
1 Auckland City Hospital, Auckland, New Zealand
² Humanitas Research Hospital, Milan, Italy
³ Janssen Research & Development, LLC, Spring House, United States
⁴ University of Calgary, Calgary, Canada
⁵ Kyorin University, Tokyo, Japan
⁶ McGill University Health Centre, Montreal, Canada
⁷ Nancy University Hospital, Université de Lorraine, Nancy, France
⁸ University of Miami Miller School of Medicine, Miami, United States
⁹ University of California San Diego, San Diego, United States
¹⁰ New York Presbyterian Weill Cornell Medical College, New York, United States
¹¹ Concord Repatriation General Hospital, Concord, Australia
¹² University Hospital Coventry & Warwickshire NHS Trust, Coventry, United Kingdom
¹³ Icahn School of Medicine at Mount Sinai, New York, United States

Topic
IBD

Session
IBD drug efficacy and safety

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)